Literature DB >> 11004327

Cost analysis of breast conservation surgery compared with modified radical mastectomy with and without reconstruction.

T K Palit1, D M Miltenburg, F C Brunicardi.   

Abstract

BACKGROUND: Breast conservation surgery (BCS), consisting of lumpectomy, axillary lymph node dissection, and radiation therapy, is as effective as modified radical mastectomy (MRM) for the treatment of early stage breast cancer. The costs of these treatment options have not been adequately addressed in the current era of increasing utilization of BCS and breast reconstruction. The purpose of this study is to determine differences in treatment costs among BCS, MRM alone, and MRM with reconstruction.
METHODS: Patients with stage I and II breast cancer receiving inpatient treatment at a private university-affiliated hospital between January 1996 and July 1997 were analyzed (n = 230). Charges were determined as follows: inpatient and radiotherapy charges from the hospital billing department, surgeon fees from group practice billing codes, and radiotherapy physician fees from the radiation oncology group practice. Inpatient length of stay was obtained from hospital medical records.
RESULTS: Average hospital inpatient charge for BCS was $4,748 (n = 74), $6,280 for MRM alone (P <0.001, n = 132), and $11,946 for MRM with reconstruction (P <0.001, n = 24). Surgeons' fees for BCS were $2,840, $3,500 for MRM alone, and $10,774 for MRM with reconstruction. The average radiotherapy charge was $18,742. Average length of stay was 1.03 days for BCS, 2.44 days for MRM alone (P <0.001), and 3.71 days for MRM with reconstruction (P <0. 001). Average total cost of BCS ($26,330) was significantly greater than the average total cost of either MRM alone ($9,780, P <0.001) or MRM with reconstruction ($22,720, P <0.001).
CONCLUSIONS: BCS is more expensive than MRM with or without reconstruction. It is the addition of radiotherapy that results in the higher total cost of CS.

Entities:  

Mesh:

Year:  2000        PMID: 11004327     DOI: 10.1016/s0002-9610(00)00383-4

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

1.  Reoperation costs in attempted breast-conserving surgery: a decision analysis.

Authors:  R E Pataky; C R Baliski
Journal:  Curr Oncol       Date:  2016-10-25       Impact factor: 3.677

Review 2.  The costs of treating breast cancer in the US: a synthesis of published evidence.

Authors:  Jonathan D Campbell; Scott D Ramsey
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

3.  A cost and benefit study of esophagectomy for patients with esophageal cancer.

Authors:  Chih-Cheng Hsieh; Ching-Wen Chien
Journal:  J Gastrointest Surg       Date:  2009-07-28       Impact factor: 3.452

4.  Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy Reform.

Authors:  Shervin M Shirvani; Jing Jiang; Anna Likhacheva; Karen E Hoffman; Simona F Shaitelman; Abigail Caudle; Thomas A Buchholz; Sharon H Giordano; Benjamin D Smith
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-02-06       Impact factor: 7.038

Review 5.  Radiation therapy planning with photons and protons for early and advanced breast cancer: an overview.

Authors:  Damien C Weber; Carmen Ares; Antony J Lomax; John M Kurtz
Journal:  Radiat Oncol       Date:  2006-07-20       Impact factor: 3.481

6.  "Entrenched practices and other biases": unpacking the historical, economic, professional, and social resistance to de-implementation.

Authors:  Theresa Montini; Ian D Graham
Journal:  Implement Sci       Date:  2015-02-13       Impact factor: 7.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.